Stock AnalizXylem (XYL) earnings for the quarter ended September 2026: EPS misses estimates
Xylem reported results for the quarter ended September 2026 on October 27, 2026. Adjusted earnings per share came in at $1.44 against the analysts’ average forecast of $1.45, a miss of 0.7%.
Revenue for the quarter was $2.20 billion, down 3.0% from $2.27 billion in the same quarter a year earlier.
The market’s verdict: the stock fell 14.2% on the first trading day after the report.
The last four quarters
Xylem has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $1.44 | $1.45 | −0.7% | −3% | −14.2% |
| Jun 2026 | $1.46 | $1.34 | +9.2% | +2% | +1.6% |
| Mar 2026 | $1.12 | $1.08 | +3.3% | +3% | −6.6% |
| Sep 2025 | $1.37 | $1.23 | +11.1% | +8% | +2.4% |
What comes next
Analysts expect EPS of $1.42 for the next quarter on average and $5.43 for the fiscal year ending December 31, 2026.
The average analyst price target is $125.44, 33% above the current price of $94.18.
Valuation and score
Xylem scores 3.4 out of 5 overall on Stock Analiz (good, with some weak spots), trades at a trailing P/E of about 20.8, and its intrinsic value under moderate assumptions is about 34% below the current market value. Full Xylem analysis with 10 years of financials
Frequently asked questions
What was Xylem’s EPS for the quarter ended September 2026?
$1.44 adjusted per share, against an analyst consensus of $1.45.
How much revenue did Xylem report?
$2.20 billion, down 3.0% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.